Skip to main content

Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer.

Publication ,  Journal Article
Edwards, DN; Ngwa, VM; Raybuck, AL; Wang, S; Hwang, Y; Kim, LC; Cho, SH; Paik, Y; Wang, Q; Zhang, S; Manning, HC; Rathmell, JC; Cook, RS ...
Published in: The Journal of clinical investigation
February 2021

Rapidly proliferating tumor and immune cells need metabolic programs that support energy and biomass production. The amino acid glutamine is consumed by effector T cells and glutamine-addicted triple-negative breast cancer (TNBC) cells, suggesting that a metabolic competition for glutamine may exist within the tumor microenvironment, potentially serving as a therapeutic intervention strategy. Here, we report that there is an inverse correlation between glutamine metabolic genes and markers of T cell-mediated cytotoxicity in human basal-like breast cancer (BLBC) patient data sets, with increased glutamine metabolism and decreased T cell cytotoxicity associated with poor survival. We found that tumor cell-specific loss of glutaminase (GLS), a key enzyme for glutamine metabolism, improved antitumor T cell activation in both a spontaneous mouse TNBC model and orthotopic grafts. The glutamine transporter inhibitor V-9302 selectively blocked glutamine uptake by TNBC cells but not CD8+ T cells, driving synthesis of glutathione, a major cellular antioxidant, to improve CD8+ T cell effector function. We propose a "glutamine steal" scenario, in which cancer cells deprive tumor-infiltrating lymphocytes of needed glutamine, thus impairing antitumor immune responses. Therefore, tumor-selective targeting of glutamine metabolism may be a promising therapeutic strategy in TNBC.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

The Journal of clinical investigation

DOI

EISSN

1558-8238

ISSN

0021-9738

Publication Date

February 2021

Volume

131

Issue

4

Start / End Page

140100

Related Subject Headings

  • Triple Negative Breast Neoplasms
  • Neoplasm Transplantation
  • Mice, Transgenic
  • Mice
  • Lymphocytes, Tumor-Infiltrating
  • Immunology
  • Immunity, Cellular
  • Humans
  • Heterografts
  • Glutamine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Edwards, D. N., Ngwa, V. M., Raybuck, A. L., Wang, S., Hwang, Y., Kim, L. C., … Chen, J. (2021). Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer. The Journal of Clinical Investigation, 131(4), 140100. https://doi.org/10.1172/jci140100
Edwards, Deanna N., Verra M. Ngwa, Ariel L. Raybuck, Shan Wang, Yoonha Hwang, Laura C. Kim, Sung Hoon Cho, et al. “Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer.The Journal of Clinical Investigation 131, no. 4 (February 2021): 140100. https://doi.org/10.1172/jci140100.
Edwards DN, Ngwa VM, Raybuck AL, Wang S, Hwang Y, Kim LC, et al. Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer. The Journal of clinical investigation. 2021 Feb;131(4):140100.
Edwards, Deanna N., et al. “Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer.The Journal of Clinical Investigation, vol. 131, no. 4, Feb. 2021, p. 140100. Epmc, doi:10.1172/jci140100.
Edwards DN, Ngwa VM, Raybuck AL, Wang S, Hwang Y, Kim LC, Cho SH, Paik Y, Wang Q, Zhang S, Manning HC, Rathmell JC, Cook RS, Boothby MR, Chen J. Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer. The Journal of clinical investigation. 2021 Feb;131(4):140100.

Published In

The Journal of clinical investigation

DOI

EISSN

1558-8238

ISSN

0021-9738

Publication Date

February 2021

Volume

131

Issue

4

Start / End Page

140100

Related Subject Headings

  • Triple Negative Breast Neoplasms
  • Neoplasm Transplantation
  • Mice, Transgenic
  • Mice
  • Lymphocytes, Tumor-Infiltrating
  • Immunology
  • Immunity, Cellular
  • Humans
  • Heterografts
  • Glutamine